Vimarsana
Biggest News Aggregation in the World

Alerts Nokia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alerts Nokia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alerts Nokia Today - Breaking & Trending Today

Zespri asks kiwifruit growers to explore a deal in China to address unauthorised plantings - Vimarsana News

Zespri asks kiwifruit growers to explore a deal in China to address unauthorised plantings

Co-operative of New Zealand producers warns that plant variety litigation is unlikely to succeed on its own

Apple, Facebook and Google still have work to do with inventor diversity - Vimarsana News

Apple, Facebook and Google still have work to do with inventor diversity

02 Jun 2021 @IAM_Alerts IPBC Global 2021 will take place at the Hyatt Regency in Seattle from 14th to 16th November, bringing the world’s I… https://t.co/WXFMHlW9gIRead more 02 Jun 2021 @IAM_Alerts IAM Long Read - Apple, Facebook and Google all have a prolific public record promoting DI&E within their organisati… https://t.co/ZVicfVj0XLRead more 02 Jun 2021 @IAM_Alerts New Zealand kiwifruit growers will vote this month on whether to explore a deal in China to address unlicensed...

Nokia and Daimler bring long-running SEP licensing dispute to an end - Vimarsana News

Nokia and Daimler bring long-running SEP licensing dispute to an end

The pair agree a settlement deal under which the Finnish company receives royalties, while Dusseldorf court referral to the CJEU falls away

Xiaomi royalty figures show importance of IP strategy as it grows international footprint - Vimarsana News

Xiaomi royalty figures show importance of IP strategy as it grows international footprint

In a banner quarter, company gets off US government blacklist, grows profits, and pays a hefty royalty sum

Australian patent extension pitfalls highlighted by recent decision - Vimarsana News

Australian patent extension pitfalls highlighted by recent decision

Ono Pharmaceutical is the latest in a series of rulings that show the need for caution when seeking all-important extension rights in the country